Delphine Pranger

Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)

Isabelle Demeestere, Judith Racapé, Julie Dechène et al. · Journal of Clinical Oncology · 2021 · 31 citations · Full text

Medicine, Endocrinology, Oncology +13

Tumor‐forming plasmacytoid dendritic cells associated with myeloid neoplasms. Report of a peculiar case with histopathologic features masquerading as lupus erythematosus

Jean‐Louis Dargent, Stéphanie Henne, Delphine Pranger et al. · Journal of Cutaneous Pathology · 2015 · 20 citations

Medicine, Dermatology, Pathology +17

Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study

Guillaume Cartron, Emmanuel Bachy, Hervé Tilly et al. · Journal of Clinical Oncology · 2023 · 19 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

RELEVANCE: Phase III randomized study of lenalidomide plus rituximab (R²) versus chemotherapy plus rituximab, followed by rituximab maintenance, in patients with previously untreated follicular lymphoma.

Nathan Fowler, Franck Morschhauser, Pierre Feugier et al. · Journal of Clinical Oncology · 2018 · 17 citations

Medicine, Oncology, Pharmacotherapy +13